Engrail Therapeutics is a clinical-stage precision-neuroscience pharmaceutical company founded in 2019 and headquartered in San Diego, California. It applies precision chemistry and pharmacology to scientifically validated mechanisms of action, developing targeted small-molecule therapies for neuropsychiatric and neurodevelopmental diseases with… - View it on GitHub